DOCSLIB.ORG

Biovision 2017-18

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biovision 2017-18 Hysel India PL 2017-18 BioVision Catalog Description Pack Size price K101-100 Annexin V-FITC Apoptosis Kit 100 assays 60991 K101-25 Annexin V-FITC Apoptosis Kit 25 assays 28373 K101-400 Annexin V-FITC Apoptosis Kit 400 assays 121973 K102-100 Annexin V-Cy3 Apoptosis Kit 100 assays 60991 K102-25 Annexin V-Cy3 Apoptosis Kit 25 assays 28373 K102-400 Annexin V-Cy3 Apoptosis Kit 400 assays 121973 K103-100 Annexin V-Cy5 Apoptosis Kit 100 assays 60991 K103-25 Annexin V-Cy5 Apoptosis Kit 25 assays 28373 K103-400 Annexin V-Cy5 Apoptosis Kit 400 assays 121973 K104-100 Annexin V-EGFP Apoptosis Kit 100 assays 60991 K104-25 Annexin V-EGFP Apoptosis Kit 25 assays 28373 K104-400 Annexin V-EGFP Apoptosis Kit 400 assays 121973 K105-100 Caspase-3 Fluorometric Assay Kit 100 assays 56736 K105-200 Caspase-3 Fluorometric Assay Kit 200 assays 79427 K105-25 Caspase-3 Fluorometric Assay Kit 25 assays 28373 K105-400 Caspase-3 Fluorometric Assay Kit 400 assays 121973 K106-100 Caspase-3 Colorimetric Assay Kit 100 assays 56736 K106-200 Caspase-3 Colorimetric Assay Kit 200 assays 79427 K106-25 Caspase-3 Colorimetric Assay Kit 25 assays 28373 K106-400 Caspase-3 Colorimetric Assay Kit 400 assays 121973 K109-100 Annexin V-Biotin Apoptosis Kit 100 assays 60991 K109-25 Annexin V-Biotin Apoptosis Kit 25 assays 28373 K109-400 Annexin V-Biotin Apoptosis Kit 400 assays 121973 K110-100 Caspase-1 Fluorometric Assay Kit 100 assays 56736 K110-200 Caspase-1 Fluorometric Assay Kit 200 assays 79427 K110-25 Caspase-1 Fluorometric Assay Kit 25 assays 28373 K110-400 Caspase-1 Fluorometric Assay Kit 400 assays 121973 K111-100 Caspase-1 Colorimetric Assay Kit 100 assays 56736 K111-200 Caspase-1 Colorimetric Assay Kit 200 assays 79427 K111-25 Caspase-1 Colorimetric Assay Kit 25 assays 28373 K111-400 Caspase-1 Colorimetric Assay Kit 400 assays 121973 K112-100 Caspase-8 Fluorometric Assay Kit 100 assays 56736 K112-200 Caspase-8 Fluorometric Assay Kit 200 assays 79427 K112-25 Caspase-8 Fluorometric Assay Kit 25 assays 28373 K112-400 Caspase-8 Fluorometric Assay Kit 400 assays 121973 K113-100 Caspase-8 Colorimetric Assay Kit 100 assays 56736 K113-200 Caspase-8 Colorimetric Assay Kit 200 assays 79427 K113-25 Caspase-8 Colorimetric Assay Kit 25 assays 28373 K113-400 Caspase-8 Colorimetric Assay Kit 400 assays 121973 K114-100 Caspase-6 Fluorometric Assay Kit 100 assays 56736 K114-200 Caspase-6 Fluorometric Assay Kit 200 assays 79427 K114-25 Caspase-6 Fluorometric Assay Kit 25 assays 28373 K114-400 Caspase-6 Fluorometric Assay Kit 400 assays 121973 K115-100 Caspase-6 Colorimetric Assay Kit 100 assays 56736 K115-200 Caspase-6 Colorimetric Assay Kit 200 assays 79427 K115-25 Caspase-6 Colorimetric Assay Kit 25 assays 28373 K115-400 Caspase-6 Colorimetric Assay Kit 400 assays 121973 [email protected] | www.hysel.co.in 1 Hysel India PL 2017-18 BioVision Catalog Description Pack Size price K116-100 Caspase-2 Fluorometric Assay Kit 100 assays 56736 K116-200 Caspase-2 Fluorometric Assay Kit 200 assays 79427 K116-25 Caspase-2 Fluorometric Assay Kit 25 assays 28373 K116-400 Caspase-2 Fluorometric Assay Kit 400 assays 121973 K117-100 Caspase-2 Colorimetric Assay Kit 100 assays 58155 K117-200 Caspase-2 Colorimetric Assay Kit 200 assays 79427 K117-25 Caspase-2 Colorimetric Assay Kit 25 assays 29791 K117-400 Caspase-2 Colorimetric Assay Kit 400 assays 121973 K118-100 Caspase-9 Fluorometric Assay Kit 100 assays 56736 K118-200 Caspase-9 Fluorometric Assay Kit 200 assays 79427 K118-25 Caspase-9 Fluorometric Assay Kit 25 assays 28373 K118-400 Caspase-9 Fluorometric Assay Kit 400 assays 121973 K119-100 Caspase-9 Colorimetric Assay Kit 100 assays 58155 K119-200 Caspase-9 Colorimetric Assay Kit 200 assays 79427 K119-25 Caspase-9 Colorimetric Assay Kit 25 assays 29791 K119-400 Caspase-9 Colorimetric Assay Kit 400 assays 121973 K120-50 Quick Apoptotic DNA Ladder Detection Kit 50 assays 55318 K121-5 Ready-to-use Apoptosis Inducer Set 5 ready-to-use 51064 apoptosis inducers K122-100 Caspase-5 Fluorometric Assay Kit 100 assays 56736 K122-200 Caspase-5 Fluorometric Assay Kit 200 assays 75173 K122-25 Caspase-5 Fluorometric Assay Kit 25 assays 28373 K122-400 Caspase-5 Fluorometric Assay Kit 400 assays 121973 K123-100 Caspase-5 Colorimetric Assay Kit 100 assays 58155 K123-200 Caspase-5 Colorimetric Assay Kit 200 assays 79427 K123-25 Caspase-5 Colorimetric Assay Kit 25 assays 29791 K123-400 Caspase-5 Colorimetric Assay Kit 400 assays 121973 K124-100 Caspase-10 Fluorometric Assay Kit 100 assays 58155 K124-200 Caspase-10 Fluorometric Assay Kit 200 assays 79427 K124-25 Caspase-10 Fluorometric Assay Kit 25 assays 28373 K124-400 Caspase-10 Fluorometric Assay Kit 400 assays 121973 K125-100 Caspase-10 Colorimetric Assay Kit 100 assays 58155 K125-25 Caspase-10 Colorimetric Assay Kit 25 assays 29791 K125-200 Caspase-10 Colorimetric Assay Kit 200 assays 79427 K125-400 Caspase-10 Colorimetric Assay Kit 400 assays 121973 K126-400 Caspase-4 Fluorometric Assay Kit 400 assays 117718 K126-100 Caspase-4 Fluorometric Assay Kit 100 assays 58155 K126-200 Caspase-4 Fluorometric Assay Kit 100 assays 79427 K126-25 Caspase-4 Fluorometric Assay Kit 25 assays 29791 K127-100 Caspase-4 Colorimetric Assay Kit 100 assays 60991 K127-200 Caspase-4 Colorimetric Assay Kit 200 assays 79427 K127-400 Caspase-4 Colorimetric Assay Kit 400 assays 121973 K127-25 Caspase-4 Colorimetric Assay Kit 25 assays 31209 K128-100 Annexin V-PE Apoptosis Detection Kit 100 assays 60991 K128-25 Annexin V-PE Apoptosis Detection Kit 25 assays 28373 K128-400 Annexin V-PE Apoptosis Detection Kit 400 assays 121973 [email protected] | www.hysel.co.in 2 Hysel India PL 2017-18 BioVision Catalog Description Pack Size price K129-100 Annexin V-PE-Cy5 Apoptosis Detection Kit 100 assays 60991 K129-25 Annexin V-PE-Cy5 Apoptosis Detection Kit 25 assays 34045 K129-400 Annexin V-PE-Cy5 Apoptosis Detection Kit 400 assays 131900 K130-50 Enhanced Apoptotic DNA Ladder Detection Kit 50 assays 55318 K131-7-25 Caspase Fluorometric Substrate Set 7 x 25 assays 69500 K132-7-25 Caspase Colorimetric Substrate Set 7 x 25 assays 69500 K133-9-25 Caspase Fluorometric Substrate Set II 9 x 25 assays 83682 K134-9-25 Caspase Colorimetric Substrate Set II 9 x 25 assays 83682 K135-7-25 Caspase Fluorometric Substrate Set Plus 7 x 25 assays 89355 K136-7-25 Caspase Colorimetric Substrate Set Plus 7 x 25 assays 89355 K137-9-25 Caspase Fluorometric Substrate Set II Plus 9 x 25 assays 103536 K138-9-25 Caspase Colorimetric Substrate Set II Plus 9 x 25 assays 103536 K139-100 Caspase-12 Fluorometric Assay Kit 100 assays 60991 K139-25 Caspase-12 Fluorometric Assay Kit 25 assays 32627 K140-100 Cathepsin B Activity Fluorometric Assay Kit 100 assays 60991 K141-100 Cathepsin K Activity Fluorometric Assay Kit 100 assays 60991 K142-100 Cathepsin L Activity Fluorometric Assay Kit 100 assays 60991 K143-100 Cathepsin D Activity Fluorometric Assay Kit 100 assays 60991 K144-100 Cathepsin S Activity Fluorometric Assay Kit 100 assays 60991 K145-100 Cathepsin H Activity Fluorometric Assay Kit 100 assays 60991 K146-100 Cathepsin G Activity Fluorometric Assay Kit 100 assays 69500 K147-100 Cathepsin B (CTSB) Inhibitor Screening Kit (Fluorometric) 100 assays 76591 K148-100 Cathepsin D Inhibitor Screening Kit (Fluorometric) 100 assays 76591 K149-100 Cathepsin S Inhibitor Screening Kit (Fluorometric) 100 assays 76591 K150-100 Cathepsin K Inhibitor Screening Kit (Fluorometric) 100 assays 79427 K151-100 Caspase-1 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K152-100 Caspase-2 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K153-100 Caspase-3 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K154-100 Caspase-4 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K155-100 Caspase-5 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K156-100 Caspase-6 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K157-100 Caspase-7 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K158-100 Caspase-8 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K159-100 Caspase-9 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K160-100 Caspase-10 Inhibitor Drug Screening Kit (Fluorometric) 100 assays 69500 K161-100 Cathepsin L Inhibitor Screening Kit (Fluorometric) 100 assays 79427 K162-100 Cathepsin G Inhibitor Screening Kit (Colorimetric) 100 assays 79427 K163-100 CaspSELECT™ Caspase-3 Immunoassay Kit (Fluorometric) 100 assays 93609 K164-100 Cathepsin H Inhibitor Screening Kit (Fluorometric) 100 assays 93609 K165-100 Cathepsin E Activity Assay Kit (Fluorometric) 100 assays 79427 K166-100 Cathepsin E Inhibitor Screening Kit (Fluorometric) 100 assays 116300 K167-100 CaspSELECT™ Caspase-7 Immunoassay Kit (Fluorometric) 100 assays 93609 K168-100 Granzyme B Activity Fluorometric Assay Kit 100 assays 66664 K169-100 Granzyme B Inhibitor Screening Kit (Fluorometric) 100 assays 83682 K170-50 Apoptotic DNA Ladder Isolation Kit 50 assays 58155 K172-100 CaspGLOWTM Fluorescein Active Caspase-12 Staining Kit 100 assays 65245 K172-25 CaspGLOWTM Fluorescein Active Caspase-12 Staining Kit 25 assays 29791 [email protected] | www.hysel.co.in 3 Hysel India PL 2017-18 BioVision Catalog Description Pack Size price K180-100 CaspGLOWTM Fluorescein Active Caspase Staining Kit 100 assays 65245 K180-25 CaspGLOWTM Fluorescein Active Caspase Staining Kit 25 assays 29791 K182-100 CaspGLOWTM Fluorescein Active Caspase-2 Staining Kit 100 assays 65245 K182-25 CaspGLOWTM Fluorescein Active Caspase-2 Staining Kit 25 assays 29791 K183-100 CaspGLOWTM Fluorescein Active Caspase-3 Staining Kit 100
Load more

Recommended publications
  • Product List March 2019 - Page 1 of 53
    Wessex has been sourcing and supplying active substances to medicine manufacturers since its incorporation in 1994. We supply from known, trusted partners working to full cGMP and with full regulatory support. Please contact us for details of the following products. Product CAS No. ( R)-2-Methyl-CBS-oxazaborolidine 112022-83-0 (-) (1R) Menthyl Chloroformate 14602-86-9 (+)-Sotalol Hydrochloride 959-24-0 (2R)-2-[(4-Ethyl-2, 3-dioxopiperazinyl) carbonylamino]-2-phenylacetic 63422-71-9 acid (2R)-2-[(4-Ethyl-2-3-dioxopiperazinyl) carbonylamino]-2-(4- 62893-24-7 hydroxyphenyl) acetic acid (r)-(+)-α-Lipoic Acid 1200-22-2 (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile 207557-35-5 1,1'-Carbonyl diimidazole 530-62-1 1,3-Cyclohexanedione 504-02-9 1-[2-amino-1-(4-methoxyphenyl) ethyl] cyclohexanol acetate 839705-03-2 1-[2-Amino-1-(4-methoxyphenyl) ethyl] cyclohexanol Hydrochloride 130198-05-9 1-[Cyano-(4-methoxyphenyl) methyl] cyclohexanol 93413-76-4 1-Chloroethyl-4-nitrophenyl carbonate 101623-69-2 2-(2-Aminothiazol-4-yl) acetic acid Hydrochloride 66659-20-9 2-(4-Nitrophenyl)ethanamine Hydrochloride 29968-78-3 2,4 Dichlorobenzyl Alcohol (2,4 DCBA) 1777-82-8 2,6-Dichlorophenol 87-65-0 2.6 Diamino Pyridine 136-40-3 2-Aminoheptane Sulfate 6411-75-2 2-Ethylhexanoyl Chloride 760-67-8 2-Ethylhexyl Chloroformate 24468-13-1 2-Isopropyl-4-(N-methylaminomethyl) thiazole Hydrochloride 908591-25-3 4,4,4-Trifluoro-1-(4-methylphenyl)-1,3-butane dione 720-94-5 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine Hydrochloride 28783-41-7 4-Chloro-N-methyl-piperidine 5570-77-4
    [Show full text]
  • Glucose Oxidase
    Catalog Number: 100289, 100330, 195196 Glucose Oxidase Molecular Weight: ~160,0001 CAS #: 9001-34-0 Physical Description: Yellow lyophilized powder Source: Aspergillus niger Isoelectric Point: 4.2 Michaelis Constants: phosphate buffer, pH 5.6; 25°C, air: Glucose: 3.3 x 10-2 mol/l(2) Glucose: 1.1 x 10-1 mol/l(3) 2-Deoxyglucose: 2.5 x 10-2 mol/l O2: 2.0 x 10-4 mol/l Structure: The enzyme contains 2 moles FAD/mole GOD. Inhibitors: Ag+, Hg2+, Cu2+ (4), 4-chloromercuribenzoate, D-arabinose (50%). FAD binding is inhibited by several nucleotides.5 pH Optimum: 6.5 pH Stability: 8.0 pH Range: 4-7 Thermal Stability: Below 40°C Description: Glucose oxidase is an FAD-containing glycoprotein. The enzyme is specific for b-D-glucose. O2 can be replaced by hydrogen acceptors such as 2.6-dichlorophenol indophenol. Relative Rates: D-glucose, 100; D-mannose, 20; 2-Deoxy-D-glucose, 20; negligible on other hexoses. Solubility: Dissolves readily at 5 mg/ml in 0.1 M potassium phosphate pH 7.0, giving a clear, yellow solution, also soluble in water Assay Procedure 1: Unit Definition: One unit of glucose oxidase is the activity which causes the liberation of 1 micromole of H2O2 per minute at 25°C and pH 7.0 under the specified conditions. Reaction: Reagents: 1. 0.1 M Phosphate Buffer, pH 6.8: dissolve 6.8 g of potassium phosphate, monobasic, anhydrous and 7.1 g of sodium phosphate, dibasic, anhydrous in about 800 ml of deionized water. Adjust the pH to 6.8 ± 0.05 @ 25°C with 1 N HCl or 1N NaOH if necessary.
    [Show full text]
  • Fructose As an Endogenous Toxin
    HEPATOCYTE MOLECULAR CYTOTOXIC MECHANISM STUDY OF FRUCTOSE AND ITS METABOLITES INVOLVED IN NONALCOHOLIC STEATOHEPATITIS AND HYPEROXALURIA By Yan (Cynthia) Feng A thesis submitted in the conformity with the requirements for the degree of Master of Science Graduate Department of Pharmaceutical Sciences University of Toronto © Copyright by Yan (Cynthia) Feng 2010 ABSTRACT HEPATOCYTE MOLECULAR CYTOTOXIC MECHANISM STUDY OF FRUCTOSE AND ITS METABOLITES INVOLVED IN NONALCOHOLIC STEATOHEPATITIS AND HYPEROXALURIA Yan (Cynthia) Feng Master of Science, 2010 Department of Pharmaceutical Sciences University of Toronto High chronic fructose consumption is linked to a nonalcoholic steatohepatitis (NASH) type of hepatotoxicity. Oxalate is the major endpoint of fructose metabolism, which accumulates in the kidney causing renal stone disease. Both diseases are life-threatening if not treated. Our objective was to study the molecular cytotoxicity mechanisms of fructose and some of its metabolites in the liver. Fructose metabolites were incubated with primary rat hepatocytes, but cytotoxicity only occurred if the hepatocytes were exposed to non-toxic amounts of hydrogen peroxide such as those released by activated immune cells. Glyoxal was most likely the endogenous toxin responsible for fructose induced toxicity formed via autoxidation of the fructose metabolite glycolaldehyde catalyzed by superoxide radicals, or oxidation by Fenton’s hydroxyl radicals. As for hyperoxaluria, glyoxylate was more cytotoxic than oxalate presumably because of the formation of condensation product oxalomalate causing mitochondrial toxicity and oxidative stress. Oxalate toxicity likely involved pro-oxidant iron complex formation. ii ACKNOWLEDGEMENTS I would like to dedicate this thesis to my family. To my parents, thank you for the sacrifices you have made for me, thank you for always being there, loving me and supporting me throughout my life.
    [Show full text]
  • Optimization of Immobilized Aldose Reductase Isolated from Bovine Liver Sığır Karaciğerinden İzole Edilen İmmobilize Aldoz Redüktazın Optimizasyonu
    Turk J Pharm Sci 2019;16(2):206-210 DOI: 10.4274/tjps.galenos.2018.81894 ORIGINAL ARTICLE Optimization of Immobilized Aldose Reductase Isolated from Bovine Liver Sığır Karaciğerinden İzole Edilen İmmobilize Aldoz Redüktazın Optimizasyonu Marya Vakıl NASLIYAN, Sidar BEREKETOĞLU, Özlem YILDIRIM* Ankara University, Faculty of Science, Department of Biology, Ankara, Turkey ABSTRACT Objectives: Isolation of enzymes and experiments on them require great effort and cost and are time-consuming. Therefore, it is important to extend the usability of the enzymes by immobilizing them. In this study our purpose was to immobilize the enzyme aldose reductase (AR) and to optimize the experimental conditions of the immobilized AR and compare them to those of free AR. Materials and Methods: AR was isolated from bovine liver and the enzyme immobilized in photographic gelatin by cross-linking with glutaraldehyde. Then the optimum conditions for free and immobilized AR in terms of pH, temperature, and storage were characterized by determining the enzyme activity. Results: Following immobilization, the optimum pH and temperature levels for free AR, which were pH 7.0 and 60°C, slightly altered to pH 7.5 and 50°C. The enzyme activity of the immobilized AR was maintained at about 65% after reusing 15 times. Moreover, immobilized AR maintained 95% of its original activity after 20 days of storage at 4°C, while the retained activity of the free AR was 85% of the original. Conclusion: Our experiments indicated that the conditions that affect enzyme activity might alter following immobilization. Once the optimum experimental conditions are fixed, the immobilized AR can be stored and reused with efficiency higher than that of free AR.
    [Show full text]
  • A High-Throughput Screening System Based on Droplet Microfluidics For
    molecules Article A High-Throughput Screening System Based on Droplet Microfluidics for Glucose Oxidase Gene Libraries Radivoje Prodanovi´c 1,2,* , W. Lloyd Ung 2, Karla Ili´c Đurđi´c 1 , Rainer Fischer 3, David A. Weitz 2 and Raluca Ostafe 4 1 Faculty of Chemistry, University of Belgrade, Studentski trg 12, 11000 Belgrade, Serbia; [email protected] 2 Department of Physics, School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA; [email protected] (W.L.U.); [email protected] (D.A.W.) 3 Departments of Biological Sciences and Chemistry, Purdue University, 207 S. Martin Jischke Dr., West Lafayette, IN 47907, USA; fi[email protected] 4 Purdue Institute of Inflammation, Immunology and Infectious Disease, Molecular Evolution, Protein Engineering and Production, Purdue University, 207 S. Martin Jischke Dr., West Lafayette, IN 47907, USA; [email protected] * Correspondence: [email protected]; Tel.: +38-111-333-6660 Academic Editors: Goran T. Vladisavljevi´cand Guido Bolognesi Received: 20 April 2020; Accepted: 15 May 2020; Published: 22 May 2020 Abstract: Glucose oxidase (GOx) is an important industrial enzyme that can be optimized for specific applications by mutagenesis and activity-based screening. To increase the efficiency of this approach, we have developed a new ultrahigh-throughput screening platform based on a microfluidic lab-on-chip device that allows the sorting of GOx mutants from a saturation mutagenesis library expressed on the surface of yeast cells. GOx activity was measured by monitoring the fluorescence of water microdroplets dispersed in perfluorinated oil. The signal was generated via a series of coupled enzyme reactions leading to the formation of fluorescein.
    [Show full text]
  • The Genome of an Industrial Workhorse
    NEWS AND VIEWS The genome of an industrial workhorse Dan Cullen Sequencing of the filamentous fungus Aspergillus niger offers new opportunities for the production of specialty chemicals and enzymes. Few microbes compare with the filamentous fungus Aspergillus niger in its ability to pro­ Environment CAT (2) H O H O + O duce prodigious amounts of useful chemicals 2 2 2 2 and enzymes. This fungus is the principal GOX (3) GLN (1) source of citric acid for food, beverages and D-glucono­ Glucose Gluconate Oxalate pharmaceuticals1 and of several important 1,5-lactone Citrate http://www.nature.com/naturebiotechnology http://www.nature.com/naturebiotechnology commercial enzymes, including glucoamy­ lase, which is widely used for the conversion of starch to food syrups and to fermentative Oxalate + acetate PEP feedstocks for ethanol production. Although OAH most of these fermentation processes are well cMDH (3) established, the underlying genetics are still cPYC (1) cACO (2) cIDH (1) poorly understood. In this issue, Pel et al.2 Pyruvate OAA MAL Citrate Isocitrate 2-ketoglutarate report the genome sequence of A. niger strain Cytosol CBS 513.88. The availability of this sequence OAT (1) CMC (2) mPYC (1) should provide invaluable aid toward improv­ Pyruvate OAA MAL Citrate Isocitrate 2-ketoglutarate ing the production of chemicals and enzymes PDH Nature Publishing Group Group Nature Publishing 7 in this organism. mMDH (1) mACO (2) mIDH (3) Pel et al. sequenced tiled bacterial artificial CS (3) 200 Acetyl-CoA TCA cycle © chromosomes representing the entire A. niger genome to produce a high-quality assembly of Mitochondrion 19 supercontigs with a combined length of 33.9 Mb.
    [Show full text]
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
    US 20190192440A1 (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0192440 A1 LI (43 ) Pub . Date : Jun . 27 , 2019 ( 54 ) ORAL DRUG DOSAGE FORM COMPRISING Publication Classification DRUG IN THE FORM OF NANOPARTICLES (51 ) Int . CI. A61K 9 / 20 (2006 .01 ) ( 71 ) Applicant: Triastek , Inc. , Nanjing ( CN ) A61K 9 /00 ( 2006 . 01) A61K 31/ 192 ( 2006 .01 ) (72 ) Inventor : Xiaoling LI , Dublin , CA (US ) A61K 9 / 24 ( 2006 .01 ) ( 52 ) U . S . CI. ( 21 ) Appl. No. : 16 /289 ,499 CPC . .. .. A61K 9 /2031 (2013 . 01 ) ; A61K 9 /0065 ( 22 ) Filed : Feb . 28 , 2019 (2013 .01 ) ; A61K 9 / 209 ( 2013 .01 ) ; A61K 9 /2027 ( 2013 .01 ) ; A61K 31/ 192 ( 2013. 01 ) ; Related U . S . Application Data A61K 9 /2072 ( 2013 .01 ) (63 ) Continuation of application No. 16 /028 ,305 , filed on Jul. 5 , 2018 , now Pat . No . 10 , 258 ,575 , which is a (57 ) ABSTRACT continuation of application No . 15 / 173 ,596 , filed on The present disclosure provides a stable solid pharmaceuti Jun . 3 , 2016 . cal dosage form for oral administration . The dosage form (60 ) Provisional application No . 62 /313 ,092 , filed on Mar. includes a substrate that forms at least one compartment and 24 , 2016 , provisional application No . 62 / 296 , 087 , a drug content loaded into the compartment. The dosage filed on Feb . 17 , 2016 , provisional application No . form is so designed that the active pharmaceutical ingredient 62 / 170, 645 , filed on Jun . 3 , 2015 . of the drug content is released in a controlled manner. Patent Application Publication Jun . 27 , 2019 Sheet 1 of 20 US 2019 /0192440 A1 FIG .
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,458,686 Clark, Jr
    United States Patent (19) 11 Patent Number: 4,458,686 Clark, Jr. 45) Date of Patent: Jul. 10, 1984 (54), CUTANEOUS METHODS OF MEASURING 4,269,516 5/1981 Lubbers et al. ..................... 356/427 BODY SUBSTANCES 4,306,877 12/1981 Lubbers .............................. 128/633 Primary Examiner-Benjamin R. Padgett 75) Inventor: Leland C. Clark, Jr., Cincinnati, Ohio Assistant Examiner-T. J. Wallen 73. Assignee: Children's Hospital Medical Center, Attorney, Agent, or Firm-Wood, Herron & Evans Cincinnati, Ohio 57 ABSTRACT (21) Appl. No.: 491,402 Cutaneous methods for measurement of substrates in 22 Filed: May 4, 1983 mammalian subjects are disclosed. A condition of the skin is used to measure a number of important sub - Related U.S. Application Data stances which diffuse through the skin or are present (62) Division of Ser. No. 63,159, Aug. 2, 1979, Pat. No. underneath the skin in the blood or tissue. According to 4,401,122. the technique, an enzyme whose activity is specific for a particular substance or substrate is placed on, in or 51). Int. Cl. ................................................ A61B5/00 under the skin for reaction. The condition of the skin is 52). U.S. Cl. .................................... 128/635; 128/636; then detected by suitable means as a measure of the 436/11 amount of the substrate in the body. For instance, the (58), Field of Search ............... 128/632, 635, 636, 637, enzymatic reaction or by-product of the reaction is 128/633; 356/41, 417, 427; 422/68; 23/230 B; detected directly through the skin as a measure of the 436/11 amount of substrate.
    [Show full text]
  • Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
    Lääkealan turvallisuus- ja kehittämiskeskus Säkerhets- och utvecklingscentret för läkemedelsområdet Finnish Medicines Agency Lääkeaineiden yleisnimet (INN-nimet) 21.6.
    [Show full text]
  • Metabolism of Carbohydrates by Pasteurella Pseudotuberculosis' R
    JOURNAL OF BACrERiOLOGY, May 1968, p. 1698-1705 Vol. 95, No. 5 Copyright 0) 1968 American Society for Microbiology Printed In U.S.A. Metabolism of Carbohydrates by Pasteurella pseudotuberculosis' R. R. BRUBAKER2 Department ofMicrobiology, The University ofChicago, Chicago, Illinois 60637 Received for publication 26 February 1968 Cell-free extracts of Pasteurella pseudotuberculosis and P. pestis catalyzed a rapid and reversible exchange of electrons between pyridine nucleotides. Although the extent of this exchange approximated that promoted by the soluble nicotinamide adenine dinucleotide (phosphate) transhydrogenase of Pseudomonas fluorescens, the reaction in the pasteurellae was associated with a particulate fraction and was not influenced by adenosine-2'-monophosphate. The ability of P. pseudotubercu- losis to utilize this system for the maintenance of a large pool of nicotinamide ade- nine dinucleotide phosphate could not be correlated with significant participation of the Entner-Doudoroff path or catabolic use of the hexose-monophosphate path during metabolism of glucose. As judged by the distribution of radioactivity in metabolic pyruvate, glucose and gluconate were fermented via the Embden-Meyerhof and Entner-Doudoroff paths, respectively. With the exception of hexosediphospha- tase, all enzymes of the three paths were detected, although little or no glucono- kinase or phosphogluconate dehydrase was present unless the organisms were cultivated with gluconate. The significance of these findings is discussed with respect to the regulation of carbohydrate metabolism in the pasteurellae, related enteric bacteria, and P. fluorescens. Glucose is catabolized by Pasteurella pestis, fate of glucose-6-phosphate in P. pestis. The the causative agent of bubonic plague, via the possibility exists, however, that excess NADP Embden-Meyerhof path (29), whereas gluconate in P.
    [Show full text]
  • Glucose Oxidase
    www.megazyme.com GLUCOSE OXIDASE ASSAY PROCEDURE K-GLOX 01/20 (200 Manual Assays per Kit) or (1960 Auto-Analyser Assays per Kit) or (2000 Microplate Assays per Kit) © Megazyme 2020 INTRODUCTION: Glucose oxidase (GOX) catalyses the oxidation of β-D-glucose to D-glucono-δ-lactone and hydrogen peroxide. It is highly specific for β-D-glucose and does not act on α-D-glucose. A major use of glucose oxidase has been in the determination of free glucose in body fluids, food and agricultural products. However, it has been gaining increasing attention in the baking industry; its oxidising effects result in a stronger dough. In some applications it can be used to replace oxidants, such as bromate and L-ascorbic acid. Other uses of glucose oxidase include the removal of oxygen from food packaging and removal of D-glucose from egg white to prevent browning. PRINCIPLE: Glucose oxidase catalyses the oxidation of β-D-glucose to D-glucono- δ-lactone with the concurrent release of hydrogen peroxide (1). In the presence of peroxidase (POD), this hydrogen peroxide (H2O2) enters into a second reaction involving p-hydroxybenzoic acid and 4-aminoantipyrine with the quantitative formation of a quinoneimine dye complex which is measured at 510 nm (2). The reactions involved are: (GOX) (1) β-D-Glucose + O2 + H2O D-glucono-δ-lactone + H2O2 (2) 2H2O2 + p-hydroxybenzoic acid + 4-aminoantipyrine (POD) quinoneimine dye + 4H2O SAFETY: The general safety measures that apply to all chemical substances should be adhered to. For more information regarding the safe usage and handling of this product please refer to the associated SDS that is available from the Megazyme website.
    [Show full text]